Safety and Efficacy of I 0401 in the Treatment of Tibial Plateau Fractures Requiring Grafting
A Phase 2 Randomized, Controlled, Open-label (Dose-blinded), Multi-center, Dose-finding Study of the Safety and Efficacy of I-0401 in the Treatment of Patients With Fractures of the Tibial Plateau Requiring Grafting.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Queensland
-
Gold Coast, Queensland, Australia, 4215
- Gold Coast Hospital (49)
-
Woollongabba, Queensland, Australia, 4102
- Princess Alexandra Hospital (45)
-
-
South Australia
-
Adelaide, South Australia, Australia, 5000
- Royal Adelaide Hospital (48)
-
-
-
-
-
Brest, France, 29200
- Hopital La Cavale Blanche (19)
-
Dunkerque, France, 59380
- Hôpital de Dunkerque (30)
-
Nancy, France, 54000
- Hôpital Central de Nancy (05)
-
Rouen, France, 76031
- Hôpital Charles Nicolle (15)
-
-
-
-
-
Berlin, Germany, 13353
- Charite, Campus Virchow Klinikum (03)
-
Duisburg, Germany, 47249
- Berufsgenossenschaftliche Unfallklinik Bochum/Duisburg (11)
-
Göttingen, Germany, 37075
- Uniklinik Göttingen (22)
-
Hannover, Germany, 30625
- Med. Hochschule Hannover (06)
-
Kiel, Germany, 24105
- Universitätsklinikum Schleswig-Holstein (40)
-
Linnich, Germany, 52441
- St.-Josef-Krankenhaus (12)
-
München, Germany, 81366
- Chirurgische Klinik der LMU (50)
-
Münster, Germany, 48149
- Universitätsklinikum Münster (39)
-
-
-
-
-
Budapest, Hungary, 1041
- Fövarosi Önkormanyzat Karolyi Sandor Korhaz es Rendelointezet (21)
-
Budapest, Hungary, 1081
- Fövarosi Önkormanyzat Peterfy Sandor utcai Korhaz-Rendelöinezet es Baleseti Központ (20)
-
Budapest, Hungary, 1125
- Fovárosi Önkormányzat Szent János Kórháza és Észak (54)
-
Györ, Hungary, 9024
- Petz Alandar County Teaching Hospital (55)
-
Szeged, Hungary, 6725
- Szegedi Egyetem AOK Kari Gyogyszertar (27)
-
-
-
-
-
Bologna, Italy, 40136
- Istituti Ortopedici Rizzoli (13)
-
Cefalù, Italy, 90015
- Fondazione Istituto San Raffaele G. Giglio di Cefalù (16)
-
Genova, Italy, 16132
- A.O. Universitaria San Martino (33)
-
Roma, Italy, 00133
- Università degli Studi di Roma "Tor Vergata" (10)
-
Roma, Italy, 00184
- A.O. San Giovanni Oddolorata (14)
-
-
-
-
-
Krakow, Poland, 31-826
- Klinika i Oddzial Kliniczny - Ortopedii i Traumatologii (36)
-
Lodz, Poland, 93-513
- Oddzial Chirurgii Ortopedyczno-Urazowej - Wojewodzki Szpital Specjalistyczny (58)
-
Piekary Slaskie, Poland, 41940
- SPZOZ Wojewodzki - Specjalistyczny Szpital Chirurgii Urazowej (35)
-
Szczecin, Poland, 71252
- Katedra i Klinika Ortopedii - Traumatologii PAM (34)
-
Warsaw, Poland, 00-909
- Wojskowy Instytut Medyczny - Centralny Szpital Kliniczny MON (60)
-
Warszawa, Poland, 02005
- Katedra I Klinika Ortopedii AM (29)
-
-
-
-
-
Madrid, Spain, 28006
- Hospital Universitario de la Princesa (18)
-
Madrid, Spain, 28220
- Hospital FREMAP Majadahonda (17)
-
Málaga, Spain, 29010
- Hospital Universitario Virgen de la Victoria (51)
-
Sevilla, Spain, 41012
- Hospital FREMAP Sevilla (32)
-
Valencia, Spain, 46009
- Hospital Universitario La Fe (07)
-
-
-
-
-
Basel, Switzerland, 4031
- Universitätsspital Basel (24)
-
Bruderholz, Switzerland, 4101
- Kantonsspital Bruderholz (25)
-
Lausanne, Switzerland, 1011
- CHUV Lausanne (02)
-
Luzern, Switzerland, 6000
- Kantonsspital Luzern (26)
-
-
Canton Zurich
-
Zurich, Canton Zurich, Switzerland, 8091
- Zurich University Hospital (01)
-
-
-
-
-
Bristol, United Kingdom, BS16 1LE
- N. Bristol NHS Trust + Univ. of Bristol (52)
-
Cardiff, United Kingdom, CF14 4XW
- University Hospital of Wales (31)
-
Norwich, United Kingdom, NR4 7UY
- Norfolk and Norwich University Hospital (44)
-
-
West Yorkshire
-
Leeds, West Yorkshire, United Kingdom, LS1 3EX
- Leeds General Infirmary (04)
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Radiological evidence of a tibial plateau fracture requiring grafting
- Females of child-bearing potential must be willing to undergo a pregnancy test (urine) prior to treatment start (at screening).
Exclusion Criteria:
- Concomitant ipsilateral fractures of the limb other than the fracture of the tibial plateau.
- Active or past history of malignant tumor.
- Evidence of systemic or localized infection at time of surgery.
- Pregnant or lactating females.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: 1
Experimental - high dose
|
1 time application
|
|
EXPERIMENTAL: 2
Experimental - low dose
|
1 time application
|
|
ACTIVE_COMPARATOR: 3
Autograft
|
1 time application
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Radiographic Images
Time Frame: All Follow-Up Visits
|
All Follow-Up Visits
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Clinical assessments of the fracture site
Time Frame: All Follow-Up Visits
|
All Follow-Up Visits
|
|
Blood parameters
Time Frame: All Follow-Up Visits
|
All Follow-Up Visits
|
|
Vital signs
Time Frame: At several Follow-Up visits
|
At several Follow-Up visits
|
|
Questionnaires of Life
Time Frame: All Follow-Up Visits
|
All Follow-Up Visits
|
|
Pharmacoeconomic evaluation
Time Frame: All Follow-Up Visits
|
All Follow-Up Visits
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Peter Messmer, MD, Zurich University Hospital, Zurich, Switzerland
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- CS I-040101/02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.